日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Publisher Correction: argeting of HIF2-driven cachexia in kidney cancer

出版商更正:针对肾癌中 HIF2 驱动的恶病质的治疗

Abu-Remaileh, Muhannad; Stransky, Laura A; Bhalerao, Nikita; Shirole, Nitin H; Jiang, Qinqin; Saad, Eddy; Machaalani, Marc; Vigeant, Sean M; Woldemichael, Hilina; Xu, Charles; Lu, Jing; Wei, Hairong; Liu, Zhihong; Sun, William; Enomoto, Kei; Choueiri, Toni K; Pitarresi, Jason R; Carr, Steven A; Udeshi, Namrata D; Kaelin, William G Jr

Targeting of HIF2-driven cachexia in kidney cancer.

针对肾癌中由HIF2驱动的恶病质的靶向治疗。

Abu-Remaileh Muhannad, Stransky Laura A, Bhalerao Nikita, Shirole Nitin H, Jiang Qinqin, Saad Eddy, Machaalani Marc, Vigeant Sean M, Woldemichael Hilina, Xu Charles, Lu Jing, Wei Hairong, Liu Zhihong, Sun William, Enomoto Kei, Choueiri Toni K, Pitarresi Jason R, Carr Steven A, Udeshi Namrata D, Kaelin William G Jr

p53 Drives Lung Cancer Regression through a TSC2/TFEB-dependent Senescence Program.

p53 通过 TSC2/TFEB 依赖的衰老程序驱动肺癌消退。

Wang Mengxiong, Bieging-Rolett Kathryn T, Kaiser Alyssa M, Brady Colleen A, Lockhart John H, Ferreira Sofia, Nguyen Kha T, Rajeevan Arati, Evans Simone A, Zhao Tianyu, Raj Nitin, Elkrief Arielle, Tischfield Sam E, Ladanyi Marc, Ozawa Michael G, Bui Nam Q, Chen Christopher T, Flores Elsa R, Attardi Laura D

Selfish chromosomes exploit a germline checkpoint to eliminate competing gametes.

自私的染色体利用生殖细胞检查点来消除竞争配子。

Ridges Jackson T, Bladen Jackson, King Thomas D, Brown Nora C, Large Christopher R L, Cooper Jacob C, Jones Amanda J, Loppin Benjamin, Dubruille Raphaëlle, Phadnis Nitin

A hormetic transcriptional program coregulates invasion, proliferation and dormancy to define metastatic potential.

兴奋性转录程序共同调节侵袭、增殖和休眠,从而决定转移潜能。

Jiménez-Castaño Raúl, Narwade Nitin, Moreno-Bueno Gema, Sánchez-Laorden Berta, Galcerán Joan, Youssef Khalil Kass, Nieto M Angela

Is CLL curable?

慢性淋巴细胞白血病可以治愈吗?

Jain, Nitin; Ferrajoli, Alessandra; O'Brien, Susan; Wierda, William

Epigenetic priming promotes tyrosine kinase inhibitor resistance and oncogene amplification

表观遗传启动促进酪氨酸激酶抑制剂耐药性和癌基因扩增

Rebecca M Starble #,Eric G Sun #,Rana Gbyli,Jonathan Radda,Jiuwei Lu,Tyler B Jensen,Ning Sun,Nelli Khudaverdyan,Ting Zhao,Bomiao Hu,Mary Ann Melnick,Shuai Zhao,Nitin Roper,Gang Greg Wang,Alan J Tackett,Yinsheng Wang,Jikui Song,Katerina Politi,Siyuan Wang,Andrew Z Xiao

A 3D ovarian cancer metastasis model using a decellularised peritoneal matrix to study therapy response.

利用脱细胞腹膜基质构建3D卵巢癌转移模型,以研究治疗反应。

Gjerde Christiane Helgestad, Kleinmanns Katrin, Langer Anika, Ruiz de Garibay Ponce Gorka, Rozmus Ezekiel, Stangeland Gina Nyhus, Leitch Calum, Elnour Rammah, Dongre Harsh Nitin, Berger Constantin, Gultekin Okan, Forcados Christopher, Stensland Maria, Nyman Tuula Anneli, Lehti Kaisa, Davidson Ben, Wälchli Sébastien, Gelebart Pascal, Costea Daniela Elena, Kotopoulis Spiros, Bjørge Line, McCormack Emmet

Allogeneic Hematopoietic Stem Cell Transplantation in Adolescents and Young Adults With Acute Lymphoblastic Leukemia-A Retrospective, Dual-Center Study

异基因造血干细胞移植治疗青少年和青年急性淋巴细胞白血病——一项回顾性双中心研究

Pasvolsky, Oren; Shimony, Shai; Saliba, Rima M; Marcoux, Curtis; Ledesma, Celina; Rondon, Gabriela; Tewari, Priti; Ragoonanan, Dristhi; Short, Nicholas J; Jabbour, Elias; Gooptu, Mahasweta; Ho, Vincent T; Soiffer, Robert J; Antin, Joseph H; Koreth, John; Cutler, Corey S; Paolino, Jonathan D; Duncan, Christine N; Lehmann, Leslie E; DeAngelo, Daniel J; Jain, Nitin; Champlin, Richard; Shpall, Elizabeth; Luskin, Marlise R; Kebriaei, Partow

Treatment adherence and clinical outcomes of osimertinib in minority patients with advanced EGFR mutated NSCLC

奥希替尼治疗EGFR突变晚期非小细胞肺癌少数族裔患者的治疗依从性和临床疗效

Lee, Matthew; Song, Junmin; Miao, Emily; Alicea, Daniel S; Zhang, Chenxin; Xue, Xiaonan; Tuckman, Steven; Yang, Jihua; D'Aiello, Angelica; Gucalp, Rasim; Stiles, Brendon; Ohri, Nitin; Halmos, Balazs; Cheng, Haiying